Dr. Silviu Brill
Institute for Pain Medicine, Tel Aviv Medical Center, Israel

Dr. Silviu Brill is Specialist in Anesthesiology and Pain Management, Director of the Institute for Pain Medicine, Tel Aviv Medical Center, Israel.
Diplomat of European Diploma of Pain Medicine (EDPM)
Director Institute for Cannabis Research, Tel Aviv Medical Centre, Israel
Honorary Secretary of European Pain Federation, Past President of the Israeli Pain Association
Dr Brill is Co-Chair of Task force on Cannabis based medicine and Chair of the Working group on Cancer Pain of European Pain Federation
Dr Brill has published about eighty articles, book chapters and other manuscripts in various areas of pain including Acute Pain, Neuropathic Pain, CRPS, Cancer-Related Pain, Opioids and Cannabinoids.
His main research interest is Neuromodulation, Psychologic aspects of Chronic Pain postsurgical neuropathic pain and Medical use of Cannabinoids.
Dr. Brill received grants from European Union, for Development of an International Pain Registry: Pain-Out, British Chevening Medical Scholarship, Israel Science Foundation, Israel Pain Association and The Israel Cancer Association.

Prof. Katarzyna Starowicz
Maj Institute of Pharmacology, Polish Academy of Sciences, Poland

Katarzyna Starowicz obtained her PhD at Utrecht University, the Kingdom of the Netherlands studying the involvement of melanocortins, with particular attention to MC4 receptor, in the mechanisms of opioid antinociception. Continuing her interest in pain research during post-doctoral internship in the Endocannabinoid Research Group supervised by Prof. Vincenzo Di Marzo she had the opportunity to work in an interdisciplinary environment studying the role of TRPV1 receptors located in the CNS and their possible involvement in pain and nociception. Subsequently, her research interests expanded to include the issue of degenerative joint disease (osteoarthritis, OA). Currently she is a neuropharmacologist and a head of the Department of Neurochemistry at the Maj Institute of Pharmacology of the Polish Academy of Sciences in Kraków (PL). She specializes in the strategies of chronic pain treatment, especially in extending the effectiveness of neuropathic and osteoarthritis pain therapy through targeting the endogenous cannabinoid system. Group’s interest is also focused on effects of endocannabinoids’ regulation of the motivational tone and cognitive impairment in chronic pain. Katarzyna currently serves as President of the International Cannabinoid Research Society (ICRS), as well as being a recipient of the ICRS Mid-Career Award. Additionally, starting from December 2024, she is a Fellow of the British Pharmacological Society (FBPhS).